EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nanoparticle-based biosensor integrated with multiple cross-displacement amplification for visual and rapid identification of hepatitis B virus and hepatitis C virus

Hang Zhang, Yuanfang Shi, Zengguang Wu, Qi Zhao, Yu Wang, Xinggui Yang, Yan Tan, Yi Wang iD, Zhenghua Xiao iD, Xu Chen iD

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.01738-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Hang Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Laboratory, the Second Affiliated Hospital, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China. Hauptthemen laut MEDLINE: Hepatitis B virus, Biosensing Techniques, Hepacivirus, Hepatitis C. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infection with hepatitis B virus (HBV) and hepatitis C virus (HCV) is a major contributor to liver-related morbidity and mortality worldwide. An accurate and rapid point-of-care (POC) diagnostic approach is the gateway for effective treatment and control of these infections. Here, for the first time, we integrated isothermal multiple cross-displacement amplification (MCDA) with a gold nanoparticle-based lateral flow biosensor (AuNPs-LFB) to successfully develop a novel HBV&HCV-MCDA-AuNPs-LFB assay for simultaneous accurate, sensitive, rapid, inexpensive, and visual identification of HBV and HCV agents. The two unique sets of MCDA degenerate primers were successfully designed targeting the S and 5′ untranslated region (5′-UTR) genes from the major HBV genotypes (B, C, D, B/C recombinant, and C/D recombinant) and HCV subtypes in China (1b, 2a, 3a, 3b, and 6a), respectively. The optimal conditions for the MCDA reaction were confirmed to be 64°C for 35 min. The MCDA products were decoded visually using the AuNPs-LFB platform, which was devised for analyzing three targets, including HBV-MCDA, HCV-MCDA amplicons, and a chromatography control. The whole detection procedure, including rapid nucleic acid extraction (~10 min), MCDA reaction (35 min), and AuNPs‐LFB interpretation (~2 min), can be completed within 50 min. The HBV&HCV-MCDA-AuNPs-LFB assay can detect the target genes (HBV- S and HCV-5′-UTR) with as low as 10 copies of gene-containing plasmid template per test and does not cross-react with other pathogens. Therefore, our preliminary results indicated that the HBV&HCV-MCDA-AuNPs-LFB assay developed in this study can potentially serve as a useful POC diagnostic tool for the identification of HBV and HCV infections. IMPORTANCE Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections have been regarded by the World Health Organization as major threats to human health, especially in low- and middle-income regions. Underdiagnosis of HBV/HCV is a particular challenge for achieving the World Health Organization’s goal of eliminating HBV and HCV infections by 2030. Here, for the first time, we integrated isothermal multiple cross-displacement amplification (MCDA) with a gold nanoparticle-based lateral flow biosensor (AuNPs-LFB) to successfully develop a novel HBV&HCV-MCDA-AuNPs-LFB assay for simultaneous accurate, sensitive, rapid, inexpensive, and visual identification and differentiation of HBV and HCV agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B virusBiosensing TechniquesHepacivirusHepatitis CNucleic Acid Amplification TechniquesHepatitis BHumansGoldMetal NanoparticlesSensitivity and SpecificityChina

Stichwörter der Autor:innen

biosensorhepatitis B virushepatitis C viruslateral flow platformmultiple cross displacement amplification

Substanzen

Gold

Autor:innen und Institutionen

  • Clinical Laboratory, the Second Affiliated Hospital, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.
  • The Second Clinical Medical College, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.
  • Department of Scientific Research, the Second Affiliated Hospital, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.
  • Department of Gastroenterology, the Second Affiliated Hospital, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, China.
  • Department of Clinical Laboratory Centre, The First People's Hospital of Guiyang, Guiyang, Guizhou, China.
  • Experimental Center, Guizhou Provincial Centre for Disease Control and Prevention, Guiyang, Guizhou, China.

ORCID-Profile: Yi Wang, Zhenghua Xiao, Xu Chen

Zitieren

APA

Zhang, H., Shi, Y., Wu, Z., Zhao, Q., Wang, Y., Yang, X., Tan, Y., Wang, Y., Xiao, Z., & Chen, X. (2025). Nanoparticle-based biosensor integrated with multiple cross-displacement amplification for visual and rapid identification of hepatitis B virus and hepatitis C virus. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01738-24

Vancouver

Zhang H, Shi Y, Wu Z, Zhao Q, Wang Y, Yang X, et al. Nanoparticle-based biosensor integrated with multiple cross-displacement amplification for visual and rapid identification of hepatitis B virus and hepatitis C virus. Microbiology Spectrum. 2025. doi:10.1128/spectrum.01738-24

BibTeX
@article{Zhang2025,
  author = {Zhang, Hang and Shi, Yuanfang and Wu, Zengguang and Zhao, Qi and Wang, Yu and Yang, Xinggui and Tan, Yan and Wang, Yi and Xiao, Zhenghua and Chen, Xu},
  title = {Nanoparticle-based biosensor integrated with multiple cross-displacement amplification for visual and rapid identification of hepatitis B virus and hepatitis C virus},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.01738-24}
}
Kostenlos starten →